CSL targets $33bn asthma market with revolutionary drug
MELBOURNE: Australia’s biggest health company CSL is aiming to crack the $US21.6bn ($33.54bn) asthma market,
MELBOURNE: Australia’s biggest health company CSL is aiming to crack the $US21.6bn ($33.54bn) asthma market,
FEATURED
Operator opens new homes for seniors in regional city
Best affordable seniors housing design for Global Awards shortlisted
Bank to support housing for seniors and people with disability
Multigenerational housing makes comeback as market conditions improve
New research confirms dementia growth in all generations
Boomer turned 1000 straw bales into a fortress-like house
INNOVATION
